Abstract: Data on the biologic activity of protocatechuic acid are contradictory; some studies have shown that it acts as an antioxidant and suppresses chemical-induced carcinogenesis and others that it induces oxidative stress and promotes tumour formation. The anticarcinogenicity of protocatechuic acid was postulated to be related, in part, to its specific suppression of neoplastic hyperproliferation. To determine whether protocatechuic acid was preferentially antiproliferative to malignant cells, non-malignant and carcinoma cells were exposed for 24 hr to protocatechuic acid (2.5 to 25 mM) and viability was assessed with the neutral red assay. The cell lines were derived from tissues of the human oral cavity, the initial site of exposure upon ingestion of dietary protocatechuic acid, and included normal GN61 gingival fibroblasts, immortalized, non-tumorigenic S-G gingival epithelial cells, and malignant HSG 1 cells derived from the salivary gland, HSC-2 cells from the floor of the oral cavity, and CAL27 cells from the tongue. Selective toxicity of protocatechuic acid to malignant cells was not observed. Furthermore, using a total cellular protein determination to quantitate cell growth, no differences in comparative sensitivities of S-G epithelial cells and HSG 1 carcinoma cells were noted in a 3 day continuous exposure to 2.5 to 12.5 mM protocatechuic acid and in recovery from a 24 hr exposure to 3 to 15 mM protocatechuic acid. The S-G and HSG 1 cells were then used to study the effects of elevated concentrations of protocatechuic acid on oxidative stress. For both cell types, protocatechuic acid induced oxidative stress, presumably through its bioactivation by a tyrosinase pathway. A brief exposure to 25 mM protocatechuic acid lowered the levels of intracellular glutathione and potentiated Fe 2π -induced lipid peroxidation of the cells. As determined with the neutral red assay, S-G and HSG 1 cells exposed briefly to a non-toxic level (0.5 mM) of the glutathione depleter, 1,3-bis(2-chloroethyl)-N-nitrosourea, were hypersensitive to a subsequent challenge with 10 mM protocatechuic acid and preexposure of the S-G and HSG 1 cells to a nontoxic level of protocatechuic acid (2.5 mM) enhanced their sensitivity to a subsequent exposure to tert-butyl hydroperoxide. These findings were consistent with protocatechuic acid, at high levels (Ø10 mM), acting as an inducer of oxidative stress.
Diet may play an important role in the development of certain diseases. Consumption of naturally occurring phenolics ubiquitous in edible vegetables, fruits, and nuts has been associated with a reduced incidence of cancer and cardiovascular diseases (Kromhout 2001; Meydani 2001; Barbaste 2002) and in reducing the risk of age-associated neurodegenerative diseases (Meydani 2001; Sun et al. 2002) . The estimated daily intake of dietary phenolic compounds is ∂1 g (Scalbert & Williamson 2000) . Several phenolic compounds have antioxidative properties and function as inhibitors of chemical mutagenesis and carcinogenesis. Reactive oxygen species, derived either from normal metabolic activities or from exposure to xenobiotics, may damage biological macromolecules, such as DNA, lipids, and proteins, resulting in subtle genotoxicity or overt cytotoxicity (Owen et al. 2000; Ferguson 2001 ).
Protocatechuic acid (3,4-dihydroxybenzoic acid; fig. 1 ), a benzoic acid derivative found in fruits, nuts, and vegetables (e.g., olives (Masella et al. 1999) ; brown rice (Hudson et al. 2000) ; pecans (Stich 1991) ), in plant-derived beverages (e.g., tea (Yen & Hsieh 2000) ; white grape wine (Li et al. 1993) ), and in herbal medicines (Liu et al. 1992; Lee & Yang 1994) , exerts contradictory biologic effects. Studies with laboratory animals demonstrated protocatechuic acid to be an efficacious anticarcinogen, inhibiting chemical-induced carcinogenesis in the liver (Tanaka et al. 1993a) , colon (Tanaka et al. 1993b) , oral cavity (Ohnishi et al. 1997; Tanaka et al. 1994) , glandular stomach , urinary bladder (Hirose et al. 1995) , pancreas (Nakamura et al. 2000a) , and skin (Tseng et al. 1998 ). Yet, in other studies, protocatechuic acid enhanced chemical-induced skin tumour promotion (Nakamura et al. 2000b ) and was not protective towards chemical-induced pulmonary carcinogenesis (Mori et al. 1999) . Furthermore, protocatechuic acid exhibited chromosomal damaging activity to Chinese hamster ovary (CHO) cells (Stich 1991) .
Studies, primarily in cell-free systems, have evaluated the antioxidant and free radical scavenging potential of protocatechuic acid. Protocatechuic acid inhibited oxidation of Cu 2π -stimulated human low-density lipoproteins (Masella et al. 1999) , peroxidation of linoleic acid (Yen & Hsieh 2000) , auto-oxidation of Fe 2π (Yoshino & Murakami 1998) , Fe 2π -induced oxidative DNA damage (Lodovici et al. 2001) , and DNA strand scission by hydroxyl radical (Ueda et al. 1996 ). Yet, in other studies with cell-free systems, protocatechuic acid, depending on its concentration, exhibited both antioxidant and prooxidant activities (Fukumoto & Mazza 2000) and was evaluated as an inferior antioxidant compared to its parent molecule, quercetin (Makris & Rossiteri 2001) . At the other extreme, protocatechuic acid was reported to induce Fe 2π /Fe 3π redox-cycle-dependent lipid peroxidation and Cu 1π /Cu 2π redox-cycle-dependent oxidative DNA damage (Nakamura et al. 2000b) .
Studies using in vitro cellular systems also have yielded divergent findings; some studies showed that protocatechuic acid acts as an antioxidant to ameliorate oxidative stress, whereas other studies just as clearly demonstrated protocatechuic acid to induce oxidative stress. Protocatechuic acid inhibited lipid peroxidation of rat hepatocyte plasma membranes, hydrogen peroxide-induced hemolysis of rat erythrocytes (Liu et al. 1992) , and tert-butyl hydroperoxide (t-BHP)-induced oxidative damage to rat primary hepatocytes (Tseng et al. 1996 ). Yet, protocatechuic acid induced oxidative stress in HL-60 human leukaemia cells (Nakamura et al. 2000b (Nakamura et al. & 2001a . The few in vivo studies directed to overt toxicity, rather than to carcinogenicity, showed that protocatechuic acid at a low dosage exerted a protective effect on oxidative stress (Liu et al. 2002) and at an elevated dosage induced oxidative stress (Nakamura et al. 2001a & b) in laboratory animals.
This study was designed to resolve specific questions regarding the toxicology of protocatechuic acid, using cultured human cells as the bioindicators. The little prior information on the effects of protocatechuic acid to mammalian cells in culture was based only on the responses of malignant cells (Lee & Yang 1994; Hudson et al. 2000; Tseng et al. 2000) . Ohnishi et al. (1997) suggested that the chemopreventative properties of protocatechuic acid towards chemical-induced carcinogenesis might be, in part, due to its suppression of the hyperproliferation of malignant cells in the target organ. The initial portion of the research reported herein used five cell lines to discern the comparative sensitivities to protocatechuic acid of malignant and nonmalignant cells. Cell lines derived from tissues in the human oral cavity were used, as this is the site initially exposed to protocatechuic acid upon ingestion of protocatechuic acid-containing foods and beverages. Thereafter, the study focused on the effect of protocatechuic acid on oxidative stress. For comparisons, these latter studies used two immortalized cell lines, one derived from non-tumorigenic gingival tissue (S-G epithelial cells) and the other from a malignant salivary gland (HSG 1 carcinoma cells). The studies performed herein provided additional information needed to better evaluate the strategy of recommending consumption of specific nutriceuticals isolated from the diet (Hudson et al. 2000; Ferguson 2001; Barbaste 2002) .
Materials and Methods
Cell cultures. The human gingival epithelioid S-G cell line was obtained from F.H. Kasten, East Tennessee State University, Quillen College of Medicine, Johnson City, TN, U.S.A. (Kasten et al. 1989 Rawls et al. 1990) , the human salivary gland carcinoma HSG 1 cell line and the human squamous carcinoma HSC-2 cell line derived from the floor of the oral cavity from H. Sakagami, Department of Dental Pharmacology, Meikai University School of Dentistry, Saitama, Japan, and the human tongue squamous carcinoma CAL 27 cell line and normal human gingival GN61 fibroblasts from D.A. Tipton, University of Tennessee, College of Dentistry, Memphis, TN, U.S.A. Cells were grown in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% foetal bovine serum (FBS), 100 U/ml penicillin G, 100 mg/ml streptomycin sulfate, and 2.5 mg/ml amphotericin B (Fungizone), termed the growth medium, and were maintained in a humidified atmosphere with 5.5% CO 2 at 37 ae. Cultures were dissociated with 0.05% trypsin-0.2% EDTA.
Test agents. 3,4-Dihydroxybenzoic acid (Fluka Chemical Co., Milwaukee, WI, U.S.A.) and 1,3-bis(2-chloroethyl)-N-nitrosourea (BCNU) (Bristol-Myers Squibb, Princeton, NJ, U.S.A.) were solubilized in ethanol. Stock concentrations were made at high enough concentrations so that when diluted prior to use, the residual solubilizing ethanol solution (AE1%) was not cytotoxic. Tyrosinase, catalase, and t-BHP (Sigma Chemical Co., St. Louis, MO, U.S.A.) were dissolved in medium or phosphate buffered saline (PBS).
Neutral red cytotoxicity assay. Individual wells of a tissue culture 96-well microtiter plate were inoculated with 0.2 ml of growth medium containing sufficient cells, approximately 3 .4¿10 4 , to provide 70% confluence after 24 hr of incubation. Thereafter, the growth medium was replaced with exposure medium, consisting of DMEM, 10% Serum Plus (JRH Biosciences, Lenexa, KS, U.S.A.), 2% FBS, and antibiotics, unamended and amended with varied concentrations of protocatechuic acid. Serum Plus is a supplement containing a low level of foetal calf serum proteins and is enhanced with specific growth promoting factors. Six to eight replicate wells were used per concentration of test agent. After 24 hr of exposure, cytotoxicity was assessed with the neutral red cytotoxicity assay, which is based on the uptake and lysosomal accumulation of the supravital dye, neutral red (Borenfreund et al. 1990) .
The protocol for the neutral red assay was as follows. A foilwrapped 4 mg/ml aqueous stock suspension of neutral red stored at room temperature was diluted to a working concentration of 40 mg/ml NR in exposure medium and incubated overnight at 37 ae. Prior to use, this solution was centrifuged to remove fine dye crystals. After a 24 hr exposure of the cells to protocatechuic acid, the medium was removed, 0.2 ml of the neutral red-containing medium was added per well, and incubation was continued for 1 hr at 37 ae. Cells were then rapidly washed and fixed with 0.2 ml of 0.5% formalin-1% CaCl 2 (vol/vol) and the neutral red incorporated into viable cells was released into the supernatant with 0.2 ml of 1% glacial acetic acid-50% ethanol. Absorbency was recorded at 540 nm with a microtiter plate spectrophotometer. Cytotoxicity graphic data were constructed as the arithmetic mean percentages of control∫S.E.M. Linear regression analysis was used to compute the concentration of protocatechuic acid needed to reduce absorbency of neutral red by 50%, termed the midpoint cytotoxicity, or neutral red 50 , value. This generalized protocol was slightly modified for use in other specific experiments designed to elucidate various factors mediating the cellular response to protocatechuic acid.
Cell proliferation assay (total cellular protein determination).
Determination of total cellular protein was used as the cytotoxicity endpoint to quantify cell growth after a 3 day continuous exposure to protocatechuic acid and to evaluate cell recovery from a 24 hr exposure to protocatechuic acid followed by a 3 day incubation in protocatechuic acid-free growth medium. The overall protocol was as follows. Cells, seeded into 96-well microtiter tissue culture plates at a density of 2.5¿10 4 cells/well, were treated with protocatechuic acid and, at various time intervals, the plates were terminated for analysis. Cells were washed twice with PBS, lysed with 50 ml of 0.1 M NaOH, and incubated for 2 hr at 37 ae, after which 0.2 ml of a 1:4 dilution of Coomassie blue (Pierce, Rockford, IL, U.S.A.) solution was added and the plate incubated at 37 ae for an additional 0.5 hr. Thereafter, absorbency was measured with a microtiter plate spectrophotometer, using 410 nm (reference) and 630 nm (absorbance) filters (Shopsis & Eng 1985) .
Glutathione assay. Measurements of cellular reduced glutathione (GSH) were performed according to the procedures of Anderson (1981) , with minor modifications (Babich & Zuckerbraun 2001) . Cells, maintained in growth medium and grown to about 70% confluence in 60 mm dishes, were washed with PBS and treated for 2 hr with PBS alone or with PBS amended either with 10 or 25 mM protocatechuic acid. Thereafter, the cells were washed with PBS, lysed with 0.2% Triton X-100 and made to contain 2.5% sulfosalicyclic acid in a total volume of 0.12 ml. After harvesting by scraping and centrifugation, acid-soluble extracts were assayed. GSH was measured spectrophotometrically at 412 nm in 0.1 ml aliquots of the acid-soluble extract by determining the oxidation of GSH by 5,5'-dithiobis(2-nitrobenzoic acid), prepared in phosphate buffer/ EDTA (pH 7.5), to glutathione disulfide (GSSG), with stoichiometric formation of 5-thio-2-nitrobenzoic acid. With each assay, a standard curve was generated with known amounts of GSH.
Lipid peroxidation. Lipid peroxidation was estimated by measuring the production of malondialdehyde in the culture supernatants. Confluent monolayers of cells in 60 mm culture dishes were washed twice with PBS, treated for 4 hr with 2 ml of PBS (control), 2 mM Fe 2π (as FeCl 2 ¡ 4H 2 O) in PBS, 25 mM protocatechuic acid in PBS, or a combination of 2 mM Fe 2π and 25 mM protocatechuic acid in PBS. Thereafter, 1 ml of 24% trichloroacetic acid was added, the cells scraped, and the resulting suspensions were centrifuged to remove precipitated proteins, and lipid peroxidation was estimated in the supernatant (which contained trichloroacetic acid at a final concentration of 8%) by measuring the concentration of malondialdehyde. Then, 1 ml aliquots of the supernatant, to which 0.5 ml of 1% thiobarbituric acid in 0.05 M NaOH was added, were heated at 95-100 ae for 20 min. After cooling, the samples were centrifuged at 1,286¿g for 10 min. (Babich et al. 1996) . Upon heating, malondialdehyde reacts with thiobarbituric acid to produce an orange-pink reaction, which was measured at an absorbency of 532 nm. An extinction coefficient of 1.56¿10 5 M ª1 was used to calculate the amount of malondialdehyde (Asakawa & Matsushita 1980) , expressed as nmol thiobarbituric acid reactive substances (TBARS) per 10 6 cells
Statistics. Experiments were performed at least three times and experimental data were presented as the arithmetic means ∫ S.E.M.
Experimental data were analyzed with a one-way analysis of variance (ANOVA) followed by Tukey's multiple range test for significant difference. To be considered statistically significant, the P value of the effect being considered must be AE0.05.
Results
As in vivo studies have shown protocatechuic acid to have anticarcinogenic properties, one aspect of the research evaluated the comparative effects of protocatechuic acid on the growth of malignant and non-malignant cells. These studies, using the decrease in uptake of neutral red as the endpoint, compared the relative 24 hr cytotoxicity of protocatechuic acid towards normal gingival GN61 fibroblasts, immortalized, non-tumorigenic S-G epithelial cells, and the three carcinoma cells lines, HSG 1 , CAL 27 and HSC-2; all cells were isolated from tissues of the human oral cavity. As noted in fig. 2 , sensitivities of the 5 cell lines to progressively increasing concentrations of protocatechuic acid were very similar. Initial toxicity (PAE0.01) occurred at 5 mM protocatechuic acid for the S-G cells, at 7.5 mM for the CAL 27 cells, and at 10 mM for the HSG 1 , HSC-2, and GN61 cells. Hereafter, all studies were performed only with the S-G and HSG 1 cells, representative of a non-malignant and a malignant cell line, respectively. Using a decrease in total cellular protein as the cytotoxicity endpoint, cell growth in response to a continuous 3 day exposure to protocatechuic acid was evaluated. In these studies, the cells were refed daily with fresh protocatechuic acid. As seen in fig. 3 , the relative growth responses towards a 3 day continuous exposure of the S-G and HSG 1 cells were similar. For both cell types, no significant decreases in the total cellular protein occurred from 2.5 to 7.5 mM protocatechuic acid; the decrease in total cellular protein noted initially at 10 mM was followed by a sharp decline (PAE0.01) at 12.5 mM protocatechuic acid.
The ability of the S-G and HSG 1 cells to recover from an initial exposure to protocatechuic acid was studied, using decrease in total cellular protein as the cytotoxicity endpoint. S-G and HSG 1 cells, exposed for 24 hr to progressively increasing concentrations of protocatechuic acid, were then washed in PBS and refed with growth medium (DMEMπ10% FBS) and incubated for another 3 days. After 1, 2, and 3 days of incubation in protocatechuic acidfree medium, individual plates were terminated and assayed for cellular protein. As noted in fig. 4 and 5, the S-G and Fig. 4 . Ability of S-G cells to recover from a 24-hr exposure to protocatechuic acid (PCA) followed by a subsequent 3 day incubation in growth medium. Toxicity was assessed by determinations of total cellular protein. The data are presented as the arithmetic means∫S.E.M. HSG 1 cells recovered, albeit at reduced growth rates, from a 24 hr exposure to 3, 6, and 9 mM protocatechuic acid. Recovery was not evident (PAE0.01) after a 24 hr exposure to 12.5 and 15 mM protocatechuic acid. Protocatechuic acid at 12.5 mM appeared to be cytostatic and at 15 mM to be cytocidal.
The second aspect of the research focused on the influence of protocatechuic acid on the redox status of the cells. Intracellular GSH levels of S-G and HSG 1 cells were greatly lowered after a 2 hr exposure to 25, but not to 10, mM protocatechuic acid in PBS ( fig. 6 ). This rapid depletion of intracellular GSH probably accounted for the enhanced cytotoxicity of protocatechuic acid noted after a 2 hr exposure in PBS, as contrasted with a 24 hr exposure in exposure medium, which contained GSH precursors, such as cysteine ( fig. 7) . Thus, with the S-G cells, the 24 hr neutral red 50 value for protocatechuic acid was 18.5 mM in medium, but was reduced to 13.2 mM for a 2 hr exposure in PBS. Similarly, for the HSG 1 cells, the 24 hr neutral red 50 value for protocatechuic acid was 18.7 mM in medium, but was lowered to 13.7 mM for a 2 hr exposure in PBS. A 0.5 hr pretreatment of the cells with a non-toxic concentration of the GSH-depleting agent, BCNU (0.5 mM in PBS), enhanced their sensitivity to a subsequent 24 hr exposure to protocatechuic acid ( fig. 8) .
Lipid peroxidation was noted in S-G and HSG 1 cells Fig. 8 . Enhancement of the cytotoxicity of protocatechuic acid (PCA) to S-G and HSG 1 cells pretreated with a nontoxic concentration of the glutathione depleter, BCNU. Toxicity was assessed with the neutral red (NR) assay. The data are presented as the arithmetic mean percentages of control∫S.E.M. * Statistically significant at PAE0.05; ** statistically significant at PAE0.01. The ability of protocatechuic acid to disturb the intracellular redox balance was further demonstrated by the enhanced sensitivity of the cells to a subsequent challenge with t-BHP, an organic peroxide. S-G and HSG 1 cells were seeded into growth medium amended with 2.5 mM protocatechuic acid and incubated for 24 hr. This concentration of protocatechuic acid, although not cytotoxic ( fig. 2) , put a subtle stress on the cells by lowering the intracellular GSH content of the S-G cells by about 20% and of the HSG 1 cells by about 13%. Fig. 10 . Potentiation of the cytotoxicity of tert-butylhydroperoxide (t-BHP) towards S-G cells pretreated for 24 hr with a nontoxic concentration (i.e., 2.5 mM) of protocatechuic acid (PCA). Toxicity was assessed with the neutral red (NR) assay. The data are presented as the arithmetic mean percentages of control∫S.E.M. Fig. 11 . Potentiation of the cytotoxicity of tert-butylhydroperoxide (t-BHP) towards HSG 1 cells pretreated for 24 hr with a nontoxic concentration (i.e., 2.5 mM) of protocatechuic acid (PCA). Toxicity was assessed with the neutral red (NR) assay. The data are presented as the arithmetic mean percentages of control∫S.E.M.
The cytotoxicity of t-BHP after a 2-, 4-, and 6-hr treatment in exposure medium (DMEM, 2% FBS, and 10% Serum Plus) was potentiated for cells pretreated with 2.5 mM protocatechuic acid ( fig. 10 and 11) .
In vegetables and fruits, protocatechuic acid is derived from a biosynthetic pathway via tyrosine (Croft 1998) . Coexposure to extracellular tyrosinase (200 U/ml), which catalyzes the oxidation of catechols to their quinone derivatives, significantly enhanced the cytotoxicity of a 2 hr exposure to 10 and 12.5 mM protocatechuic acid in PBS ( fig. 12) . Tyrosinase is also involved in biochemical pathways leading to the formation of melanin. The development of a brown coloration in an initially colorless solution of protocatechuic acid in PBS was evident upon addition of tyrosinase. A Fig. 12 . Enhancement of the cytotoxicity of protocatechuic acid (PCA) towards S-G and HSG 1 cells in the presence of 200 U/ml tyrosinase. Toxicity was assessed with the neutral red (NR) assay. The data are presented as the arithmetic mean percentages of control ∫S.E.M. * Statistically significant at PAE0.01. similar brown coloration of protocatechuic acid-amended PBS occurred in the presence of S-G and HSG 1 cells, indicating, albeit qualitatively, that these cells exhibited tyrosinase activity.
Discussion
There are no published studies on the comparative sensitivities of malignant and non-malignant cells to protocatechuic acid. As noted herein, sensitivity to a 24 hr exposure to protocatechuic acid was independent of whether the cells were malignant (HSG 1 , HSC-2, CAL 27), non-malignant (S-G), or normal (GN51). In further studies with the S-G and HSG 1 cells, no differences in sensitivity between the two cell lines were observed in their responses to a 3 day continuous exposure to protocatechuic acid and in their ability to a recover from a 24 hr exposure to protocatechuic acid. From the studies presented herein, there was no indication that the chemopreventative property of protocatechuic acid was due to its specific suppression of neoplastic hyperproliferation, as suggested by Ohnishi et al. (1997) .
The cytotoxicity of protocatechuic acid to cells in culture was dependent on the experimental design and on the specific cytotoxic endpoint examined. For a 24 hr exposure to protocatechuic acid in exposure medium (DMEM π 10% Serum Plusπ2% FBS) the neutral red 50 value was 18.5 mM for S-G cells and 18.7 mM for HSG 1 cells. Whereas, for a 2 hr exposure to protocatechuic acid in PBS, the respective neutral red 50 values were 13.2 and 13.7 mM. Hudson et al. (2000) observed that protocatechuic acid exerted equivalent cytotoxicities to human colon-derived and breast-derived carcinoma cells in a cell proliferation assay. However, in a clonogenic assay, the colon cancer cells were eight times more sensitive to protocatechuic acid than were the breast cells.
Using cell-free systems, protocatechuic acid was shown to exhibit antioxidant and free radical scavenging properties (Ueda et al. 1996; Yoshino and Murakami 1998; Masella et al. 1999; Yen & Hseih 2000) . However, with in vitro cellular systems, the data are divided as to whether protocatechuic acid acts as an antioxidant and is protective against oxidative stress (Liu et al. 1992; Tseng et al. 1996 Tseng et al. & 1998 or whether protocatechuic acid is biotransformed to a compound(s) that lack antioxidative properties and induce oxidative stress (Nakamura et al. 2000b (Nakamura et al. , 2001a . The findings reported herein with the S-G and HSG 1 cells were in accord with the studies of Nakamura et al. (2000b Nakamura et al. ( , 2001a , who showed that protocatechuic acid, at elevated levels, acts as an inducer of oxidative stress. Nakamura et al. (2000b Nakamura et al. ( & 2001a demonstrated, in vivo using a mouse skin assay and in vitro with human HL-60 leukaemia cells, that tyrosinase bioactivated protocatechuic acid to a reactive compound, probably a quinone. This activated metabolite, apparently, then depleted intracellular GSH, leading to disturbance of cellular detoxification systems and to oxidative stress, as noted by an increase in TBARS. Studies with the S-G and HSG 1 cells supported this hypothesis. As noted by Nakamura et al. (2001a) with HL-60 cells, the cytotoxicity of protocatechuic acid to S-G and HSG 1 cells was enhanced in the presence extracellular tyrosinase. The cytotoxic response of the S-G and HSG 1 cells to protocatechuic acid was characteristic of the cellular response towards an agent that induces oxidative stress. Glutathione, a thiol-containing tripeptide, is a significant part of the cellular defense against reactive oxygen species. Intracellular levels of GSH were depleted upon exposure of the cells to protocatechuic acid in PBS. Furthermore, the rapid depletion of intracellular GSH probably accounted for the enhanced cytotoxicity of protocatechuic acid noted after a brief, 2 hr exposure in PBS contrasted with a longer, 24 hr exposure in exposure medium containing GSH precursors. BCNU, an irreversible inhibitor of glutathione reductase, inhibits the recycling of GSSG to GSH. S-G and HSG 1 cells pretreated with BCNU, a depleter of GSH, exhibited increased sensitivity to a subsequent challenge with protocatechuic acid. Lastly, protocatechuic acid significantly potentiated the auto-oxidation of Fe 2π leading to TBARS formation.
The apparent contradictory data in the literature on the biological activity of protocatechuic acid may reflect differences in experimental design, specifically in the concentration of protocatechuic acid. With regards to the effects of protocatechuic acid on tumuor formation, the dosage of test agent, apparently, was a prime factor in determining its biological activity. For example, in their study of skin tumor formation with dimethylbenz[a]anthracene-initiated mice, Nakamura et al. (2000b) noted that topical pretreatment with 16 nmol protocatechuic acid inhibited 12-0-tetradecanoylphorbol-13-acetate (TPA)-induced papilloma formation, whereas pretreatment with 1,600 nmol protocatechuic acid enhanced TPA-induced papilloma formation. The chemopreventive properties of protocatechuic acid, at low dosages, were attributed to its antioxidative properties (Owen et al. 2000) , its inhibitory action towards hepatic P450 activities (Baer-Dubowska et al. 1998) , and its suppression of malignant cell proliferation (Ohnishi et al. 1997) . The carcinogenic activity of high dosages of protocatechuic acid were attributed to its alteration of the cellular redox balance, noted by a lessening of intracellular GSH, and to its disturbance on subsequent detoxification of electrophilic toxicants, including ultimate carcinogens (Nakamura et al. 2001b) .
Similarly, the dosage of protocatechuic acid was critical in mediating its in vivo antioxidant or prooxidant effects towards overt toxicity. Thus, pretreatment of rats with protocatechuic acid (50 to 100 mg/kg) caused elevation of liver GSH and had a protective effect on t-BHP-induced hepatotoxicity (Liu et al. 2002) . Conversely, a 3 hr treatment of mouse skin with 20 mmol protocatechuic acid enhanced tyrosinase activity, leading to oxidative stress responses such as a lessened level of intracellular GSH, leukocyte infiltration, and hydrogen peroxide generation (Nakamura et al. 2000b (Nakamura et al. & 2001a . A toxic dose of protocatechuic acid (i.e., 500 mg/kg) greatly lowered the GSH level in mouse liver and kidney and subchronic administration of protocatechuic acid (0.1% in drinking water) lowered the level of GSH in mouse kidney. GSH-depleted mice (i.e., mice treated with buthionine sulfoximine, an inhibitor of GSH synthesis) were hypersensitive to protocatechuic acid (Nakamura et al. 2001b) . Similarly, as noted herein, an elevated concentration of protocatechuic acid lowered the intracellular GSH levels in the S-G and HSG 1 cells. A decrease in intracellular GSH occurred only after a 2 hr exposure in PBS to 25, but not to 10, mM protocatechuic acid and BCNUtreated, GSH-depleted S-G and HSG 1 cells were hypersensitive to protocatechuic acid.
A similar approach may explain the divergent data on the in vitro cytotoxicity of t-BHP as mediated by protocatechuic acid. Pretreatment of rat hepatocytes with 0.05 mg/ml (∑0.32 mM) protocatechuic acid, a nontoxic concentration, afforded some protection against a subsequent challenge with t-BHP (Tseng et al. 1996) . However, pretreatment of the S-G and HSG 1 cells with 2.5 mM protocatechuic acid, a concentration that caused some depletion of intracellular GSH, potentiated the toxicity of t-BHP.
Although quantification of the daily amount of protocatechuic acid consumed in vegetables, fruits, and beverages has not been evaluated, ingestion by daily food intake even at a dose of 1 mg/kg of body weight would be difficult to achieve (Nakamura 2000b) . Thus, the concentrations employed herein, as well as those by Nakamura et al. (2000b Nakamura et al. ( , 2001a , are applicable to predicting the potential consequences of an overexposure to polyphenolics in general, and to protocatechuic acid in particular. This is of concern because of the availability, and hence safety to human health, of antioxidants administered excessively as pills and tablets and containing polyphenolics extracted and concentrated from fruits and vegetables. This duality in biological activity of polyphenolics, acting both as antioxidants and prooxidants, has been recognized, although the mechanisms accounting for this duality need clarification. Considerable research has focused on the identification and elucidation of the mechanism of action of specific compounds isolated from dietary sources that might prevent or postpone the onset of cancer and other health risks, such as cardiovascular disease. Such research may eventually lead to the dispensation of rational advice concerning the potential usefulness of particular diets and the prudence of recommending consumption of specific nutriceuticals isolated from the diet (Barbaste 2002; Ferguson 2001; Hudson et al. 2000; Stich 1991; Tanaka et al. 1995) .
